Prudential PLC Legend Biotech Corp Transaction History
Prudential PLC
- $19.6 Billion
- Q3 2024
A detailed history of Prudential PLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Prudential PLC holds 26,822 shares of LEGN stock, worth $1.01 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
26,822
Previous 22,256
20.52%
Holding current value
$1.01 Million
Previous $985,000
32.69%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding LEGN
# of Institutions
225Shares Held
73.7MCall Options Held
279KPut Options Held
350K-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$423 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$284 Million5.1% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$251 Million7.41% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$216 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.04MShares$191 Million1.16% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.33B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...